JNJ-1761981

· Johnson & Johnson Enterprise Innovation Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-1761981, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-1761981 in Participants With Solid Tumors [Phase 1]